Albaño, Crispina I.

HRN: 08-71-24  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/23/2025
CEFTRIAXONE 1G (VIAL)
11/23/2025
11/30/2025
IV
2g
OD
Infected AVF
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines